Prozkoumejte pracovní příležitosti ve společnosti Novartis v seznamu níže. Operater v proizvodnji trdnih izdelkov (m/ž/d) Temporary (Fixed Term), Full time Production / Manufacturing Slovenia ...

Nürnberg, 06. Juli 2026 – Tatjana Dreyer hat zum 1. Juli 2026 die Position als Head Communications & Patient Advocacy bei Novartis Deutschland übernommen. In dieser Funktion gehört sie dem Country ...

Explore opportunities with Novartis and Sandoz below. For additional roles with Novartis Gene Therapies (formerly AveXis) visit the GTx Career Search.

Strengthens the Novartis oncology pipeline with two lead ADC assets and a broader payload platform with potential impact ...

Jako firma globalna, czujemy ogromną odpowiedzialność za otaczający nas świat i mamy świadomość posiadania możliwości tworzenia pozytywnej zmiany społecznej. Novartis współpracuje z przedstawicielami ...

Board member since March 2023 Nationality: British/American | Year of birth: 1964 A scientist by training, John D. Young has over 35 years of experience in the healthcare industry and brings a wealth ...

Transforming the treatment and healthcare system landscape using early interventions, pioneering treatments, and innovative partnerships to avoid preventable mortality from cardiovascular disease (CVD ...

“One of the things I love about working for Novartis is the trust the company has in us. They allow us to work flexibly – so that we can balance our lives, our families and making an impact with our ...

Age-related diseases, including neurodegenerative diseases and cardiovascular and metabolic diseases, account for a substantial and rising portion of the global health burden. DARe scientists are ...

The mental health and wellbeing of our people is fundamental to who we are at Novartis. As an extension of our purpose to improve and extend people’s lives, we are committed to supporting our people ...

Basel, July 2, 2026 – Novartis today announced that the European Commission (EC) has approved Itvisma ® (onasemnogene ...

All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the ...